|
- 2018
β2肾上腺素受体通过HIF-1α调控NNK诱导的胰腺癌细胞进展
|
Abstract:
摘要:目的 探讨β2肾上腺素受体在4-甲基亚硝氨基-3-吡啶-1-丁酮(NNK)诱导胰腺癌细胞进展中的具体作用机制。方法 采用NNK干预胰腺癌MIA PaCa-2和BxPC-3细胞,通过HIF-1α-shRNA稳定转染胰腺癌细胞及运用ICI 118551,以NNK组作为对照,Transwell小室侵袭试验检测各组胰腺癌细胞的侵袭能力,Western blot检测HIF-1α、Cyclin D1和VEGF蛋白表达水平。流式细胞技术检测各组细胞周期变化。结果 NNK能够显著上调MIA PaCa-2和BxPC-3细胞HIF-1α水平及促进胰腺癌细胞的增殖及侵袭能力;β2肾上腺素受体抑制剂ICI 118551及sh-HIF-1α能够显著下调NNK所诱导的MIA PaCa-2和BxPC-3细胞HIF-1α水平,以及抑制胰腺癌细胞的增殖及侵袭能力。另外,运用CoCl2上调HIF-1α表达水平后能够逆转ICI 118551对NNK效应的抑制作用,重新上调胰腺癌细胞的侵袭能力。 结论 β2肾上腺素受体通过HIF-1α来介导NNK诱导的胰腺癌细胞增殖及侵袭。
ABSTRACT: Objective To explore the mechanism of β2-adrenogenic receptor mediating the progression of NNK-induced pancreatic cancer cells. Methods Pancreatic cancer cell lines (MIA PaCa-2 and BxPC-3) were incubated with NNK. ShRNA targeting HIF-1α was applied to knockdown HIF-1α expression. ICI 118551 was used to inhibit β2-adrenogenic receptor signaling. Invasion of MIA PaCa-2 and BxPC-3 cells was detected by Transwell assay. The protein expressions of HIF-1α, Cyclin D1 and VEGF were determined by Western blot. Cell cycle was determined by flow cytometric analysis. Results NNK could significantly upregulate HIF-1α expression in MIA PaCa-2 and BxPC-3 cells and increase the invasion and proliferation of pancreatic cancer cells. However, ICI 118551 or sh-HIF-1α could reverse the effect of NNK on MIA PaCa-2 and BxPC-3 cells. Furthermore, when HIF-1α expression was upregulated by CoCl2, the inhibitory effect of ICI 118551 on NNK was reversed, with a prominent increase in pancreatic cancer cell invasion. Conclusion β2-adrenogenic receptor mediates the invasion and proliferation of NNK-induced pancreatic cancer cells through HIF-1α
[1] | SHAN T, MA Q, ZHANG D, et al. β2-adrenoceptor blocker synergizes with gemcitabine to inhibit the proliferation of pancreatic cancer cells via apoptosis induction[J]. Eur J Pharmacol, 2011, 665(1-3):1-7. |
[2] | AL-WADEI MH, AL-WADEI HA, SCHULLER HM. Effects of chronic nicotine on the autocrine regulation of pancreatic cancer cells and pancreatic duct epithelial cells by stimulatory and inhibitory neurotransmitters[J]. Carcinogenesis, 2012, 33(9):1745-1753. |
[3] | SCHULLER HM. Effects of tobacco constituents and psychological stress on the beta-adrenergic regulation of non-small cell lung cancer and pancreatic cancer: Implications for intervention[J]. Cancer Biomark, 2013, 13(3):133-144. |
[4] | SCHULLER HM, AL-WADEI HA. Beta-adrenergic signaling in the development and progression of pulmonary and pancreatic adenocarcinoma[J]. Curr Cancer Ther Rev, 2012, 8(2):116-127. |
[5] | ZHANG D, MA Q, WANG Z, et al. β2-adrenoceptor blockage induces G1/S phase arrest and apoptosis in pancreatic cancer cells via Ras/Akt/NFκB pathway[J]. Mol Cancer, 2011, 10:146. |
[6] | HUANG XY, WANG HC, YUAN Z, et al. Norepinephrine stimulates pancreatic cancer cell proliferation, migration and invasion via β-adrenergic receptor-dependent activation of P38/MAPK pathway[J]. Hepatogastroenterology, 2012, 59(115):889-893. |
[7] | 徐军,穆维靖,沙焕臣,等. β2受体阻滞剂对胰腺癌细胞侵袭能力的影响及其机制[J]. 西安交通大学学报(医学版), 2012, 33(5):549-554. |
[8] | ZHANG D, LEI J, MA J, et al. β2-adrenogenic signaling regulates NNK-induced pancreatic cancer progression via upregulation of HIF-1α[J]. Oncotarget, 2016, 7(14):17760-17772. |
[9] | SCHULLER HM, AL-WADEI HA, ULLAH MF, et al. Regulation of pancreatic cancer by neuropsychological stress responses: A novel target for intervention[J]. Carcinogenesis, 2012, 33(1):191-196. |
[10] | SCHAAL C, CHELLAPPAN SP. Nicotine-mediated cell proliferation and tumor progression in smoking-related cancers[J]. Mol Cancer Res, 2014, 12(1):14-23. |
[11] | SHAN T, MA J, MA Q, et al. β2-AR-HIF-1α: A novel regulatory axis for stress-induced pancreatic tumor growth and angiogenesis[J]. Curr Mol Med, 2013, 13(6):1023-1034. |
[12] | KIM-FUCHS C, LE CP, PIMENTEL MA, et al. Chronic stress accelerates pancreatic cancer growth and invasion: A critical role for beta-adrenergic signaling in the pancreatic microenvironment[J]. Brain Behav Immun, 2014, 40:40-47. |
[13] | PARTECKE LI, SPEERFORCK S, K?FDING A, et al. Chronic stress increases experimental pancreatic cancer growth, reduces survival and can be antagonised by beta-adrenergic receptor blockade[J]. Pancreatology, 2016, 16(3):423-433. |
[14] | HEFNER J, CSEF H, KUNZMANN V. Stress and pancreatic carcinoma―β-adrenergic signaling and tumor biology[J]. Dtsch Med Wochenschr, 2014, 139(7):334-338. |